BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

698 related articles for article (PubMed ID: 21897221)

  • 1. Mechanisms and treatment of hypercalcemia of malignancy.
    Clines GA
    Curr Opin Endocrinol Diabetes Obes; 2011 Dec; 18(6):339-46. PubMed ID: 21897221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
    Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of malignancy associated hypercalcemia].
    Tai N; Inoue D
    Clin Calcium; 2014 Aug; 24(8):1223-8. PubMed ID: 25065875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Malignancy-associated hypercalcemia].
    Yamaguchi K
    Gan To Kagaku Ryoho; 1991 Mar; 18(3):343-9. PubMed ID: 2003737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone.
    Clines GA; Guise TA
    Endocr Relat Cancer; 2005 Sep; 12(3):549-83. PubMed ID: 16172192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of malignancy-associated hypercalcemia].
    Endo I; Inoue D
    Clin Calcium; 2006 Apr; 16(4):665-69. PubMed ID: 16582519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of resistant hypercalcemia of malignancy with a proposed treatment algorithm.
    McMahan J; Linneman T
    Ann Pharmacother; 2009 Sep; 43(9):1532-8. PubMed ID: 19622757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rare case of chronic lymphocytic leukemia with hypercalcemia induced by elevated parathyroid hormone-related peptides.
    Kampfenkel T; Baraniskin A; Teschendorf C; Schmiegel W; Massenkeil G
    Acta Haematol; 2010; 124(1):57-60. PubMed ID: 20616540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypercalcemia of malignancy--new insights into an old syndrome.
    Esbrit P
    Clin Lab; 2001; 47(1-2):67-71. PubMed ID: 11214225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of humoral hypercalcemia of malignancy in rats with inhibitors of carbonic anhydrase.
    Brown GM; Morris CA; Mitnick MA; Insogna KL
    J Bone Miner Res; 1990 Oct; 5(10):1037-41. PubMed ID: 1964358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypercalcemia in malignancy].
    Eto S
    Rinsho Byori; 1994 Sep; 42(9):943-51. PubMed ID: 7967119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypercalcemia and bone resorption in malignancy.
    Walls J; Bundred N; Howell A
    Clin Orthop Relat Res; 1995 Mar; (312):51-63. PubMed ID: 7634618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bone targeting agents: bisphosphonates].
    Debiais F
    Bull Cancer; 2013 Nov; 100(11):1199-206. PubMed ID: 24158668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercalcemia of malignancy: the central role of parathyroid hormone-related protein.
    Wysolmerski JJ; Broadus AE
    Annu Rev Med; 1994; 45():189-200. PubMed ID: 8198376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy.
    Oyajobi BO; Anderson DM; Traianedes K; Williams PJ; Yoneda T; Mundy GR
    Cancer Res; 2001 Mar; 61(6):2572-8. PubMed ID: 11289133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of cancer-induced hypercalcemia.
    Rosol TJ; Capen CC
    Lab Invest; 1992 Dec; 67(6):680-702. PubMed ID: 1460860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approach to diagnosis and treatment of hypercalcemia in a patient with malignancy.
    Reagan P; Pani A; Rosner MH
    Am J Kidney Dis; 2014 Jan; 63(1):141-7. PubMed ID: 24021907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral hypercalcemia of malignancy. The role of parathyroid hormone-related protein.
    Insogna KL
    Endocrinol Metab Clin North Am; 1989 Sep; 18(3):779-94. PubMed ID: 2673773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium and vitamin D supplementation during bisphosphonate administration may increase osteoclastic activity in patients with bone metastasis.
    Altundag O; Altundag K; Selim Silay Y; Gunduz M; Demircan K; Gullu I
    Med Hypotheses; 2004; 63(6):1010-3. PubMed ID: 15504568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-induced hypercalcemia.
    Lumachi F; Brunello A; Roma A; Basso U
    Anticancer Res; 2009 May; 29(5):1551-5. PubMed ID: 19443365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.